We are live on !
Find out more
Wealth Effects Portfolio holdings
AUM
$370M
Turnover
11.85%
1-Year Est. Return
63.53%
This Fund
S&P 500
This Quarter Est. Return
-8.7%
1 Year Est. Return
+63.53%
3 Year Est. Return
+235.33%
5 Year Est. Return
+296.22%
10 Year Est. Return
–
AUM
$203M
AUM Growth
-$24.7M
(-11%)
Cap. Flow
+$4.89M
Cap. Flow % of AUM
Cap. Flow %
2.42%
Top 10 Holdings %
Top 10 Hldgs %
43.06%
Holding
208
New
6
Increased
82
Reduced
72
Closed
11
Avg Time Held
1.4
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.51M |
| 2 |
Seelos Therapeutics, Inc. Common Stock
SEEL
|
+$2.21M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$538K |
| 4 |
Novo Nordisk
NVO
|
+$492K |
| 5 |
Eli Lilly
LLY
|
+$428K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$491K |
| 2 |
Devon Energy
DVN
|
+$435K |
| 3 |
United Rentals
URI
|
+$332K |
| 4 |
NVIDIA
NVDA
|
+$315K |
| 5 |
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
|
+$308K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.16% |
| 2 | Technology | 21.99% |
| 3 | Miscellaneous | 20.79% |
| 4 | Communication Services | 8.08% |
| 5 | Financials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AVDL
1
DELISTED
Avadel Pharmaceuticals
AVDL
| $24.8M | 12.25% |
2,409,289
+40,200
| +2% | +$538K |
2021 Q4
7 quarters
|
|
|
2
Apple
AAPL
$5.19T
| $15.4M | 7.61% |
90,059
-2,677
| -3% | -$491K |
2021 Q4
7 quarters
|
|
|
3
NVIDIA
NVDA
$3.93T
| $10.4M | 5.14% |
239,210
-7,040
| -3% | -$315K |
2021 Q4
7 quarters
|
|
4
Amazon
AMZN
$2.87T
| $7.28M | 3.59% |
57,263
-711
| -1% | -$95.3K |
2021 Q4
7 quarters
|
|
5
Microsoft
MSFT
$3.9T
| $6.38M | 3.15% |
20,220
-404
| -2% | -$133K |
2021 Q4
7 quarters
|
|
6
Vanguard Morningstar Total Stock Market ETF
VTI
$688B
| $5.71M | 2.82% |
26,867
+501
| +2% | +$111K |
2022 Q4
3 quarters
|
|
7
Arrowhead Research
ARWR
$6.71B
| $4.43M | 2.19% |
164,750
+700
| +0.4% | +$21.4K |
2021 Q4
7 quarters
|
|
8
JPMorgan Chase
JPM
$915B
| $4.33M | 2.14% |
29,872
-297
| -1% | -$44.5K |
2021 Q4
7 quarters
|
|
9
Alphabet (Google) Class A
GOOGL
$3.63T
| $4.3M | 2.13% |
32,890
+150
| +0.5% | +$19.4K |
2021 Q4
7 quarters
|
|
|
10
Meta Platforms (Facebook)
META
$1.64T
| $4.12M | 2.03% |
13,726
+11,656
| +563% | +$3.51M |
2023 Q2
1 quarter
|
|
11
Trade Desk
TTD
$7.48B
| $3.93M | 1.94% |
50,345
+3,075
| +7% | +$249K |
2021 Q4
7 quarters
|
|
12
Blackstone
BX
$94.5B
| $3.01M | 1.49% |
28,075
-221
| -0.8% | -$23K |
2021 Q4
7 quarters
|
|
13
iShares Core S&P 500 ETF
IVV
$874B
| $2.25M | 1.11% |
5,230
+32
| +0.6% | +$14.3K |
2022 Q4
3 quarters
|
|
14
Chevron
CVX
$427B
| $2.02M | 1% |
11,969
-33
| -0.3% | -$5.33K |
2021 Q4
7 quarters
|
|
15
JPMorgan Equity Premium Income ETF
JEPI
$46.5B
| $1.95M | 0.96% |
36,334
+3,172
| +10% | +$175K |
2022 Q3
4 quarters
|
|
16
Pfizer
PFE
$164B
| $1.87M | 0.93% |
56,493
+3,663
| +7% | +$130K |
2021 Q4
7 quarters
|
|
17
iShares Core S&P Total US Stock Market ETF
ITOT
$95.4B
| $1.86M | 0.92% |
19,742
+36
| +0.2% | +$3.54K |
2022 Q4
3 quarters
|
|
18
AbbVie
ABBV
$522B
| $1.79M | 0.88% |
11,981
-49
| -0.4% | -$7.19K |
2021 Q4
7 quarters
|
|
|
19
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.55B
| $1.73M | 0.85% |
36,598
-6,485
| -15% | -$308K |
2021 Q4
7 quarters
|
|
20
Tesla
TSLA
$1.54T
| $1.66M | 0.82% |
6,648
-465
| -7% | -$119K |
2021 Q4
7 quarters
|
|
21
Berkshire Hathaway Class B
BRK.B
$1.26T
| $1.65M | 0.82% |
4,722
| – | – |
2021 Q4
7 quarters
|
|
22
Merck
MRK
$364B
| $1.6M | 0.79% |
15,541
-585
| -4% | -$63.1K |
2021 Q4
7 quarters
|
|
23
Boeing
BA
$136B
| $1.58M | 0.78% |
8,248
+318
| +4% | +$69.6K |
2021 Q4
7 quarters
|
|
24
Johnson & Johnson
JNJ
$690B
| $1.56M | 0.77% |
10,016
-4
| -0% | -$660 |
2021 Q4
7 quarters
|
|
25
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
| $1.55M | 0.77% |
33,742
+10
| +0% | +$478 |
2021 Q4
7 quarters
|
|
Similar funds
BC
Wealth Effects's Q3 2023 Portfolio in Review
As of Q3 2023, Wealth Effects held 208 positions worth $203M, down 11% from $227M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Wealth Effects's Q3 2023 filing shows 6 new, 82 increased, 72 reduced and 11 closed positions. Its largest new stake was Novo Nordisk: 5,581 shares worth $508K. The largest sale was Apple, an estimated $491K.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 28% a quarter earlier, followed by Technology and Miscellaneous.
- Wealth Effects's largest Q3 2023 buy was Novo Nordisk: 5,581 shares worth $508K.
- Wealth Effects added most to Meta Platforms (Facebook) in Q3 2023, an estimated $3.51M increase.
- Wealth Effects's biggest Q3 2023 reduction was Apple, cutting an estimated $491K.
- Wealth Effects fully exited Peabody Energy in Q3 2023, selling an estimated $294K.
- Wealth Effects's ten largest holdings make up 43% of its $203M portfolio in Q3 2023.
- Wealth Effects opened 6 new positions and closed 11 in Q3 2023.
- Wealth Effects's portfolio value fell 11% quarter-over-quarter to $203M.
Based on Wealth Effects's 13F filing for Q3 2023, filed 16 Oct 2023.